Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

4 May 2021 15:25

RNS Number : 5113X
Maven Income and Growth VCT 5 PLC
04 May 2021
 

Maven Income and Growth VCT 5 PLC (the Company)

 

Issue of Equity

 

On 23 October 2020, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £10 million, with an over-allotment facility for up to a further £10 million (the Offer). On 8 February 2021, the Company announced that the Board of the Company had resolved to exercise its discretion to utilise the over-allotment facility of £10 million. On 1 April 2021, the Company announced that, as the over-allotment facility had been utilised in full, the Offer had closed fully subscribed.

 

Pursuant to the Offer, and the £783,550 of valid applications received in respect of the 2021/2022 tax year, the Company has issued and allotted 2,071,074 new Ordinary Shares on 4 May 2021. In accordance with the allotment formula set out in the Prospectus for the Offer, the offer prices at which the shares were issued were in the range of 37.37p to 38.34p per Ordinary Share.

 

In respect of this allotment, an application will be made by the Company to the FCA Listing Authority and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 10 May 2021.

 

Following this final allotment, a total of 53,810,605 Ordinary Shares have been issued by the Company pursuant to the Offer, and the number of Ordinary Shares now in issue is 177,166,525. Therefore, the total number of voting rights in the Company is 177,166,525.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Company Secretary

 

4 May 2021

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDKQBBQBKDKPK
Date   Source Headline
21st May 201310:32 amRNSNet Asset Value(s)
20th May 201312:12 pmRNSNet Asset Value(s)
17th May 201311:49 amRNSNet Asset Value(s)
16th May 201310:20 amRNSNet Asset Value(s)
15th May 201310:26 amRNSNet Asset Value(s)
14th May 20131:05 pmRNSNet Asset Value(s)
13th May 201311:56 amRNSNet Asset Value(s)
10th May 201311:14 amRNSNet Asset Value(s)
9th May 201312:08 pmRNSNet Asset Value(s)
8th May 201312:36 pmRNSNet Asset Value(s)
7th May 201310:02 amRNSNet Asset Value(s)
3rd May 201311:51 amRNSNet Asset Value(s)
2nd May 201312:10 pmRNSNet Asset Value(s)
1st May 20131:52 pmRNSNet Asset Value(s)
30th Apr 20131:00 pmRNSNet Asset Value(s)
29th Apr 201312:45 pmRNSNet Asset Value(s)
26th Apr 20132:59 pmRNSIssue of Equity
26th Apr 201310:10 amRNSNet Asset Value(s)
24th Apr 201311:24 amRNSNet Asset Value(s)
23rd Apr 201312:23 pmRNSNet Asset Value(s)
22nd Apr 20131:08 pmRNSNet Asset Value(s)
19th Apr 20133:36 pmRNSInterim Management Statement
19th Apr 201312:01 pmRNSNet Asset Value(s)
18th Apr 201312:39 pmRNSNet Asset Value(s)
17th Apr 201310:06 amRNSNet Asset Value(s)
16th Apr 20131:28 pmRNSDirectorate Change
16th Apr 20131:26 pmRNSResult of AGM
16th Apr 201311:29 amRNSNet Asset Value(s)
15th Apr 201311:51 amRNSDirector/PDMR Shareholding
15th Apr 201311:45 amRNSNet Asset Value(s)
12th Apr 201311:42 amRNSNet Asset Value(s)
11th Apr 201310:44 amRNSNet Asset Value(s)
10th Apr 201311:49 amRNSNet Asset Value(s)
9th Apr 201312:39 pmRNSNet Asset Value(s)
8th Apr 20132:43 pmRNSNet Asset Value(s)
8th Apr 20137:00 amRNSIssue of Equity
5th Apr 20133:26 pmRNSNet Asset Value(s)
4th Apr 201311:40 amRNSNet Asset Value(s)
3rd Apr 201310:48 amRNSNet Asset Value(s)
2nd Apr 20133:33 pmRNSNet Asset Value(s)
28th Mar 201311:20 amRNSNet Asset Value(s)
27th Mar 201310:58 amRNSNet Asset Value(s)
26th Mar 20132:22 pmRNSNet Asset Value(s)
25th Mar 201311:56 amRNSNet Asset Value(s)
22nd Mar 20132:23 pmRNSNet Asset Value(s)
21st Mar 201312:02 pmRNSNet Asset Value(s)
20th Mar 201310:08 amRNSNet Asset Value(s)
19th Mar 20139:43 amRNSNet Asset Value(s)
18th Mar 20134:28 pmRNSFinal Results
18th Mar 201311:57 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.